Switching drugs from prescription (Rx) to over-the-counter (OTC) status is a commercial strategy that has been growing in popularity. Successful switches are as much an art as a science, and it has become increasingly apparent that switch teams must revise their best practices in strategy, marketing, sales, clinical research, regulatory affairs, medical writing, labeling, and packaging if they are to effectively collaborate and lead an Rx product through the switch to OTC.
Now in its fifth consecutive year, our
Rx-to-OTC Switch Summit is the most advanced thought leadership event experts can attend to discuss all aspects of a switch, from the NDA process to the final over-the-counter product; analyze current trends, and prepare for future switches. Whether you are exploring your chances of tapping into the very lucrative OTC marketplace or are an expert in the field, this conference will provide detailed presentations, intensive case studies and collaborative panel discussions relevant to your interests.
Top Five Reasons to Attend:
- Discuss key research on branding with respect to the OTC consumer shopping and choice experience
- Explore how to use new technologies, new ways of thinking, and new regulatory developments to advance consumer self-care
- Analyze evolving legislation and the changing laws and regulations impacting OTC products
- Learn how key indication, safety and dosing messages from Rx labeling get translated to ''consumer-friendly'' Drug Facts label (DFL) language
- Design intuitive, effective comprehension alternate models to expand consumer access
Who Should Attend:
This conference is designed for professionals from pharmaceutical companies with responsibilities in the following areas:
- Rx-to-OTC Switches
- Consumer Healthcare Products
- Marketing/Brand Management/Product Management
- Regulatory Affairs/Regulatory Processes
- Clinical Development
- Legal Affairs/Counsel/Regulatory Counsel
- Medical/Scientific Affairs
- Clinical Trials
- Research and Development
- Business Strategy
- Labeling/Packaging
- Drug Delivery Technology
- Product Development
- Corporate Development
This event is also of interest to:
- Strategy and Marketing Consultants
- Clinical Research Labs
- CROs/CMOs
- Drug After-Market Manufacturers/Suppliers
- Legal/Regulatory Advisors
- Statistical Service Providers
- Marketing Organizations
Speakers
- Meredith Balderas, Sr. Brand Manager Differin OTC/Acne, Consumer Business Unit, GALDERMA
- Susan Lavine Coleman, President, NCI CONSULTING, INC.
- Terri Goldstein, Chief Executive Officer, THE GOLDSTEIN GROUP
- Edwin Hemwall, Ph.D., Principal, EDWIN HEMWALL LLC REGULATORY AND SCIENTIFIC CONSULTING SERVICE
- Dr. Juby Jacob-Nara, Former CMO, and Vice President, Global Clinical Development and Global Medical Affairs, PFIZER
- Susan Levy, Founder and Principal, SUSAN B. LEVY CONSULTING
- Rikin Mehta, Vice President, Regulatory Affairs and Quality Assurance, AQUESTIVE, Former FDA Deputy Division Director and Policy Lead, NSURE
- Amy Replogle, Director Rx-to-OTC Switch Science, BAYER
- Katherine Rouse, Director of Marketing, GALDERMA
- Randall Thornton, Clinical Pharmacist, EMORY HEALTHCARE
- Paul Wardle, Vice President, U.S. Women's Health, HRA PHARMA
- Allie Wollum, MPH, Senior Project Manager, IBIS REPRODUCTIVE HEALTH
Please fill in your name and email to receive the Summit Agenda of this event.
Venue
Sonesta Philadelphia Downtown Rittenhouse Square
1800 Market St, 19103
Philadelphia, PA, USA
Venue
Sonesta Philadelphia Rittenhouse Square1800 Market Street
Philadelphia, PA 19103
Explore the comfort and fresh, contemporary vibe at Sonesta Philadelphia Downtown Rittenhouse Square. A premier choice among hotels in Philadelphia, enjoy spacious, modern accommodations and luxurious amenities while staying in the heart of downtown and only steps away from Rittenhouse Square.
To make reservations please call 1.800.SONESTA and request the negotiated rate for ExL 15th Metrics, 5th RX to OTC, E-Consent. You may also make reservations online using the button below:
Click HereThe group rate is available until November 15, 2017. Please book your room early as rooms available at this rate are limited.
